Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
- Age 18 years or older.
- Patients with confirmed or suspected lung cancer who require EBUS-TBNA as part of
their staging investigations of the mediastinum will be considered for the trial.
- Patients with undiagnosed enlarged lymph nodes in the mediastinum suspicious for lung
cancer in which a tissue diagnosis is required.
- Patients who are deemed on clinical grounds not to be medically fit for a
- Patients where there is a high clinical suspicion of lymphoma.
Type of Study:
Time Perspective: Prospective
The primary objective of this study is to perform gene alteration analysis using samples obtained by EBUS-TBNA in lung cancer patients.
Outcome Time Frame:
Kazuhiro Yasufuku, MD
Canada: Ethics Review Committee
- Lung Cancer
- undiagnosed enlarged
- lymph nodes
- Lung Neoplasms